Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.

Current treatment options in oncology - 21 Jun 2018

Ollila Thomas A, Olszewski Adam J

Abstract excerpt

OPINION STATEMENT: Diffuse large B cell lymphoma (DLBCL) arises from extranodal organs in about 30% of cases. Its prognosis and risk of recurrence in the central nervous system (CNS) vary according to the primary site of origin. Recent studies begin to clarify these differences using molecular classification. Testicular, breast, and uterine DLBCL (as well as possibly primary cutaneous DLBCL, leg-type) share a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Central Nervous System Neoplasms
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Management

Share to Disease Susceptibility

Share to Immunohistochemistry

Share to Lymphoma, Large B-Cell, Diffuse

Share to Risk Assessment

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 29931605
DOI: 10.1007/s11864-018-0555-8
PMCID: PMC6294323

Genes

MYD88
BCL2
BCL6
MYC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.PMID 29931605Read ↗

Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System.Semantic proximity Read ↗

A retrospective analysis of clinicopathological and genetic features of synchronous CNS and systemic DLBCL at diagnosis.Semantic proximity Read ↗

Clinical Analysis of the Importance of Central Nervous System (CNS) Involvement in Rare Primary Sinonasal Diffuse Large B-cell Lymphoma (PSDLBCL)Semantic proximity Read ↗

Pathology and new insights in central nervous system lymphomas.Semantic proximity Read ↗

Comparative Study on the Clinicopathologic and Molecular Characteristics of Primary and Secondary Diffuse Large B-cell Lymphoma in the Central Nervous System.Semantic proximity Read ↗

Targetable genetic features of primary testicular and primary central nervous system lymphomasSemantic proximity Read ↗

Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrenceSemantic proximity Read ↗

Testicular large B‐cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCLSemantic proximity Read ↗

Consolidative breast radiotherapy and prophylactic high-dose methotrexate are important first-line treatments for primary breast diffuse large B-cell lymphoma patients treated with R-CHOP-like regimensSemantic proximity Read ↗

Heterogeneity in primary gastrointestinal DLBCL: from clinical management to molecular mechanisms and treatment strategies.Semantic proximity Read ↗

Diffuse large B cell lymphoma: using pathologic and molecular biomarkers to define subgroups for novel therapySemantic proximity Read ↗

Primary bone diffuse large B-cell lymphoma (PB-DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB-like mutational profile and good prognosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.